CANCER GENETICS INC - COM (CGIX)

CUSIP: 13739U104

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM
Total 13F shares
4,089,825
Share change
-23,172
Total reported value
$4,252,000
Price per share
$1.04
Number of holders
23
Value change
-$22,545
Number of buys
11
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 13739U104?
CUSIP 13739U104 identifies CGIX - CANCER GENETICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CANCER GENETICS INC - COM (CGIX) as of Q3 2018

As of 30 Sep 2018, CANCER GENETICS INC - COM (CGIX) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,089,825 shares. The largest 10 holders included PERKINS CAPITAL MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, Stonepine Capital Management, LLC, Vanguard Group Inc, GRANAHAN INVESTMENT MANAGEMENT INC/MA, Fairbanks Capital Management, Inc., GEODE CAPITAL MANAGEMENT, LLC, DIKER MANAGEMENT LLC, WEDBUSH SECURITIES INC, and Virtu Financial LLC. This page lists 23 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.